← Back to home
Comparison · Analytics

DoseFinding vs forestly

A side-by-side editorial comparison of DoseFinding and forestly — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs forestly: at a glance

FeatureDoseFindingforestly
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingclinical-safety, adverse-events, data-visualization, r-language
Last editorial update45m ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is forestly?

forestly built an interactive safety review tool, then taught it to produce submission-ready RTF.

forestly renders adverse-event forest plots as interactive reactable widgets — filterable by AE category, with sliders for incidence thresholds and a toggle for the risk-difference column. Version 0.1.3 added `rtf_static_forestly()` for static RTF output, and 0.1.4 has been about giving the display owner control over what reviewers see: the CSV download button, the AE filter label, and the diff toggle can each be switched off.

Read the full forestly trajectory →

DoseFinding vs forestly: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

F
forestly
ANALYTICS
0.0

forestly built an interactive safety review tool, then taught it to produce submission-ready RTF.

◆ Current state

forestly renders adverse-event forest plots as interactive reactable widgets — filterable by AE category, with sliders for incidence thresholds and a toggle for the risk-difference column. Version 0.1.3 added `rtf_static_forestly()` for static RTF output, and 0.1.4 has been about giving the display owner control over what reviewers see: the CSV download button, the AE filter label, and the diff toggle can each be switched off.

◆ Where it's heading

The arc runs from a fixed interactive widget toward a configurable one with two output modes. Nearly every new argument in the last two releases exists to remove something from the display or relabel it, which suggests the users driving development are producing outputs for others to review under conventions they do not control. The x-axis range, column header, figure header and slider range arguments point the same way — this is a tool being fitted into standardised reporting rather than used ad hoc.

◆ Prediction

Given that the last two releases have consisted almost entirely of display-control arguments, the next is likely more of the same, applied to whichever parts of the interactive layout are still fixed.

Alternatives to DoseFinding and forestly

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or forestly.

See all DoseFinding alternatives → · See all forestly alternatives →

Recent activity from DoseFinding and forestly

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agoforestlyDownload button, AE filter label and diff toggle become optional
  2. 11mo agoforestlyStatic RTF forest plots join the interactive output
  3. 1y agoDoseFindingConditional and predictive power for interim analyses
  4. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  5. 1y agoforestlyreactR 0.6.0 rendering fix and slider label control
  6. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  7. 2y agoforestlyTreatment group selection and rough-edge fixes
  8. 2y agoDoseFindingCompliance update for R-devel
  9. 3y agoforestlyFirst release on GitHub and CRAN
  10. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and forestly?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and forestly are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than forestly?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and forestly are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to forestly?

Top forestly alternatives in Analytics are ranked by recent ship velocity. Browse the "forestly alternatives" section above for the current picks, or visit /alternatives/forestly for the full list with editorial commentary on each.